Reduced Total Blood Loss and Blood Transfusion in Non-Septic Revision Knee Arthroplasty Using a Bipolar Sealer
1 other identifier
interventional
60
1 country
1
Brief Summary
To investigate if the use of a bipolar sealer for skin and capsula incision results in decreased total blood loss and/or less blood transfusion in non-septic knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 20, 2015
CompletedFirst Posted
Study publicly available on registry
April 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedAugust 17, 2015
April 1, 2015
1.8 years
April 20, 2015
August 13, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Estimated blood loss
2nd postoperative morning
Secondary Outcomes (3)
Blood loss
1st. postoperative morning
Blood transfusion
while hospitalized expected 5 days.
Readmission
90 days after surgery
Study Arms (2)
Bipolar sealer
ACTIVE COMPARATORProspective use of bipolar sealer for skin and knee capsule incision revisions of non-septic knee arthroplasty.
Scalpel
PLACEBO COMPARATORConventional surgical incision with scalpel - data extracted from a retrospective group.
Interventions
Prospective trial with Aquamantys for surgical skin and capsula incision w a retrospective control group using a conventional scalpel skin and capsula incision.
Eligibility Criteria
You may qualify if:
- Patients undergoing Non septic knee-arthroplasty revision.
- Musk speak and understand Danish
You may not qualify if:
- Age below 18.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hvidovre University Hospital
Hvidovre, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 20, 2015
First Posted
April 28, 2015
Study Start
October 1, 2013
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
August 17, 2015
Record last verified: 2015-04